LifeGlue Technologies
Clinical-grade hyaluronic-acid bioink/hydrogel platform (Glue4Life) for tissue engineering and regenerative medicine — scalable biomaterial production + 3D bioprinting (human stem cells). Univ. of Tampere spin-out (2024). Arctic15 100 Innovations winner 2026.
The row
- Stage
- Pre-revenue — No sales yet
- Location
- Tampere
- Founded
- 2024
- Research origin
- Tampere Univ.
- Business ID
- 3496759-4 · Finnish trade register
- Funding
- EstBAN angel funding (2026)
Links
Where this sits on the map
LifeGlue Technologies is one of 33 companies in Therapeutics & Diagnostics. The others:
How this row was decided
Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗